Print

Orchid Chemicals & Pharmaceuticals Ltd.
Unaudited Financial Results for nine months ended December 31, 2007
(Rs.Lakhs)
   
Standalone Results
Consolidated Results
S.No
 Particulars
Three months ended
31-Dec-07
(Unaudited)
Three months ended
31-Dec-06
(Unaudited)
Nine months ended 31-Dec-07 (Unaudited)
 Nine months ended 31-Dec-06 (Unaudited) Year ended 31-Mar-07 (Audited)
Nine months ended 31-Dec-07 (Unaudited)
Nine months ended 31-Dec-06 (Unaudited)
Year ended 31-Mar-07 (Audited)
1
 Sales and Operating Income
33,268.90
23,873.33
86,601.52
68,617.44
93,417.55
90,847.92
72,127.92
98,508.07
2
 Other Income
30.15
26.36
90.74
126.56
155.98
4.01
151.69
35.62
3
 Total Income
33,299.05
23,899.69
86,692.26
68,744.00
93,573.53
90,851.93
72,279.61
98,543.69
4
 Expenditure
a) Decrease/(Increase) in Stock in trade
248.44
(3,461.05)
(7,813.06)
(12,862.76)
(14,012.10)
(7,791.09)
(12,924.33)
(13,745.93)
b) Material cost
9,619.24
10,389.34
31,217.57
34,430.63
42,899.90
34,171.89
35,626.19
46,752.05
c) Purchase of Traded Goods
923.31
625.28
2,357.59
1,557.45
2,167.75
2,357.59
1,557.45
2,357.59
  d) Staff Cost
2,823.59
1,924.01
7,439.57
5,734.23
7,772.57
8,642.36
5,859.64
9,244.64
  e) Depreciation / Amortisation
2,357.80
2,038.14
6,889.02
5,979.82
8,246.73
7,075.27
6,181.48
8,508.92
f) Other Expenditure
9,839.55
6,956.33
26,624.31
18,495.23
26,360.09
27,255.62
21,634.10
26,992.84
  g) Total
25,811.93
18,472.05
66,715.00
53,334.60
73,434.94
71,711.64
57,934.53
80,110.11
5
Profit from Ordinary Activities before Interest & Exceptional item (3-4)
7,487.12
5,427.64
19,977.26
15,409.40
20,138.59
19,140.29
14,345.08
18,433.58
6
 Interest and Finance Charges
1,951.96
2,644.21
5,685.23
7,406.35
9,830.65
5,776.07
7,483.68
9,929.15
7
 Profit from Ordinary Activities before Exceptional Item (5-6)
5,535.16
2,783.43
14,292.03
8,003.05
10,307.94
13,364.22
6,861.40
8,504.43
8
 Exceptional Item
642.54
344.92
7904.52
104.46
751.24
7904.52
104.46
751.24
9
 Profit before Tax after Exceptional Item (7+8)
6,177.70
3,128.35
22,196.55
8,107.51
11,059.18
21,268.74
6,965.86
9,255.67
10
 Tax Expenses
    - Current Tax & Deferred Tax
727.97
250.00
5,222.75
750.00
1,230.00
5,222.75
750.00
1,230.00
    - Fringe Benefit Tax
38.00
46.00
105.00
121.00
166.00
105.00
121.00
170.78
11
 Net Profit After Tax (9-10)
5,411.73
2,832.35
16,868.80
7,236.51
9,663.18
15,940.99
6,094.86
7,854.89
12
 Paid- up Equity Share Capital (Face value of Rs. 10 each)
6,583.70
6,581.57
6,583.70
6,581.57
6,581.63
6,583.70
6,581.57
6,581.63
13
 Reserves excluding Revaluation Reserves
-
-
-
-
43,542.57
-
-
41,928.64
14
 Basic Earnings per Share (EPS) Rs.*
8.20*
4.31*
25.55*
11.01*
14.70
24.15*
9.11*
11.96
15
 Diluted Earnings per Share (EPS) Rs.*
5.51*
3.85*
17.16*
9.84*
13.23
16.22*
8.15*
10.76
16
 Aggregate of Public Shareholding
  - Number of equity shares
50241854
54031568
50241854
54031568
50833619
  -Percentage of Shareholding
76.31
82.10
76.31
82.10
77.24
* EPS is for the period (not annualised)
  • The Company is operating in single segment (i.e) "Pharmaceuticals".
  • In accordance with the revised AS 15, necessary provision has been made for the employee benefits during the period. The increase in liability as at the commencement of the year as per revised AS 15 will be adjusted against the opening reserves in accordance with the said standard.
  • Exceptional item represents exchange gain on outstanding Foreign Currency Convertible Bonds. Tax expenses include tax on Exceptional item
    of Rs. 3075.50 lakhs for the nine months ended December 31, 2007 and Rs. 291.20 lakhs for the quarter ended december 31, 2007.
  • The Allotment Committee of the Board has allotted shares as follows:
    - 6000 shares at an adjusted price of Rs.200.44 per share to employees under ORCHID ESOP 1999 Scheme on October 18, 2007.
    - 3000 shares at an adjusted price of Rs.200.44 per share to employees under ORCHID ESOP 1999 Scheme on December 20, 2007.
    - 12750 shares at an adjusted price of Rs.200.44 per share to employees under ORCHID ESOP 1999 Scheme and 1000 shares at a price of Rs.193.25 per share to employees under ORCHID ESOP 2005 Scheme on January 17, 2008.
  • The Company received 4 complaints during the quarter ended December 31, 2007 from the shareholders. All the complaints have been resolved and no complaints were pending as on December 31, 2007.
  • The above financial results were taken on record by the Board of Directors at its meeting held on Thursday, January 17, 2008.
  • The standalone accounts have been subjected to limited review by the Statutory Auditors.
  • Previous period figures have been regrouped wherever necessary.

Place : Chennai
Date : January 17, 2008

For and on behalf of the Board

K.Raghavendra Rao
Managing Director